View Older Stories

May 11, 2026 07:10AM BridgeBio Pharma (BBIO) PT Raised to $110 at H.C. Wainwright

May 8, 2026 06:10AM BridgeBio Pharma (BBIO) files mixed shelf

May 8, 2026 05:06AM BridgeBio Pharma (BBIO) PT Raised to $130 at Evercore ISI

May 8, 2026 12:54AM BridgeBio Pharma Inc. (BBIO) Misses Q1 EPS by 16c

May 6, 2026 07:32AM BridgeBio gets Brazil approval for ATTR-CM heart drug acoramidis

May 1, 2026 06:00AM Barclays sees a buying opportunity in this biotech stock

Apr 29, 2026 07:19AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Apr 28, 2026 03:23PM BridgeBio Pharma (BBIO) PT Raised to $96 at BofA Securities

Apr 28, 2026 02:00PM Raymond James on BridgeBio Pharma (BBIO): 'We expect continued strong commercial momentum for Attruby'

Apr 28, 2026 12:14PM Barclays on BridgeBio Pharma (BBIO): 'We see buying opportunity on weakness, reiterate top idea'

Apr 28, 2026 11:46AM TD Cowen on BridgeBio Pharma (BBIO): 'A key overhang is removed now'

Apr 28, 2026 11:41AM RBC Capital on BridgeBio Pharma (BBIO): 'we remain buyers'

Apr 28, 2026 11:34AM William Blair: 'we continue to view BridgeBio as a core smidcap biotech holding'

Apr 28, 2026 11:25AM Mizuho on BridgeBio Pharma (BBIO): 'Not Best Case but Still Good Outcome Relative to Street'

Apr 28, 2026 09:48AM Mizuho: 'BBIO could potentially trade in the $90-110+ range today / near-term'

Apr 28, 2026 09:38AM Barclays: 'We think dropping the question of '441 validity from the case is a major development'

Apr 28, 2026 07:31AM BridgeBio teams with Morgan Freeman to raise awareness of heart condition

Apr 27, 2026 09:29AM Piper Sandler Reiterates Overweight Rating on BridgeBio Pharma (BBIO)

Apr 27, 2026 06:48AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Apr 20, 2026 10:46AM Mizuho sees Pfizer patent trial as the single largest catalyst for BridgeBio (BBIO) stock this year

Apr 20, 2026 08:32AM Piper Sandler Reiterates Overweight Rating on BridgeBio Pharma (BBIO)

Apr 15, 2026 05:10PM Jefferies on BridgeBio Pharma (BBIO): expecting Attruby sales to beat consensus estimates

Apr 8, 2026 04:15PM RBC Capital Starts BridgeBio Pharma (BBIO) at Outperform

Apr 8, 2026 12:12PM Barclays Positive on BridgeBio Pharma (BBIO): 'We expect continued strength from Attruby launch'

Mar 31, 2026 06:41AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Mar 30, 2026 03:30PM BridgeBio's acoramidis reduces mortality risk in heart disease patients

Mar 30, 2026 01:30PM Jefferies on BridgeBio Pharma (BBIO): 'Net-net, $1B+ peak sales seems reasonable'

Mar 30, 2026 09:50AM William Blair: 'we view BridgeBio as a core smidcap biotech holding'

Mar 30, 2026 07:31AM BridgeBio submits drug application to FDA for rare muscle disease

Mar 18, 2026 03:35PM BridgeBio Pharma (BBIO) PT Raised to $106 at Mizuho

Mar 12, 2026 09:24AM Leerink Partners Reiterates Outperform Rating on BridgeBio Pharma (BBIO) after data presentation: "risk/reward skewed to the upside"

Mar 10, 2026 12:42PM Barclays Reiterates Overweight Rating on BridgeBio Pharma (BBIO) amid tafamidis IP trial update

Mar 10, 2026 06:34AM William Blair Starts BridgeBio Pharma (BBIO) at Outperform

Feb 24, 2026 05:16PM BridgeBio Pharma Inc. (BBIO) Misses Q4 EPS by 28c

Feb 20, 2026 11:34AM BridgeBio Pharma (BBIO) Gains Tied to Market Chatter

Feb 12, 2026 10:03AM BridgeBio Pharma (BBIO) PT Raised to $89 at Raymond James

Feb 12, 2026 07:56AM TD Cowen comments on BridgeBio Pharma following positive infigratinib data

Jan 30, 2026 11:42AM Barclays Starts BridgeBio Pharma (BBIO) at Overweight

Jan 21, 2026 04:14PM BridgeBio issues $632.5 million convertible notes due 2033

Jan 12, 2026 01:42PM TD Cowen Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Jan 12, 2026 10:31AM BridgeBio reports $362.4 million in Attruby revenue for 2025

Jan 6, 2026 02:11AM Morgan Stanley Starts BridgeBio Pharma (BBIO) at Overweight

Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note

Dec 21, 2025 08:00PM Here's the list of top biotech stocks to own for 2026

Dec 11, 2025 12:58AM Bernstein SocGen Group Starts BridgeBio Pharma (BBIO) at Outperform

Nov 10, 2025 02:33AM BridgeBio's acoramidis shows mortality benefit in ATTR-CM variant patients

Oct 30, 2025 09:39AM BridgeBio Pharma (BBIO) PT Raised to at TD Cowen as 'Attruby Beats Expectations Again'

Oct 30, 2025 06:20AM BridgeBio Pharma (BBIO) PT Raised to $100 at Goldman Sachs

Oct 30, 2025 05:37AM BridgeBio Pharma (BBIO) PT Raised to $75 at Leerink Partners

Oct 29, 2025 04:13PM BridgeBio Pharma Inc. (BBIO) Misses Q3 EPS by 7c

View Older Stories